Total Funding
15
33
Total FundingSeries C raised
Growth Score 15 in past quarter
-2 pts
Heat Score 33 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
135483
Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.
- Ehud Marom: FounderPast Role: Teva Pharmaceuticals, VP of Operations
- Irit Zalayet: CFO
About the Company
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great
unmet needs - Parkinson's disease (PD) and Cancer.

